All Posts: non-small cell lung cancer
2 Articles
- News Release
Georgetown Investigator Presents Final PAPILLON Trial Results Showing Long-Term Survival in a Subset of Lung Cancer
Final results from the landmark PAPILLON trial, which changed the standard of care for a difficult-to-treat rare form of lung cancer, confirm that amivantamab, when added to…
September 14, 2026
- News Release
Investigational Drug Shows Promise in a Clinical Trial for Lung Cancers With ALK Mutations
Early signals from phase 1 of the ALKOVE-1 clinical trial suggest potential benefit from the use of an investigational drug called NVL-655 in people whose non-small cell lung…
November 8, 2024